Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet
[ad_1] New Delhi, January 22 India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side
Read More[ad_1] New Delhi, January 22 India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side
Read MoreNY.- He New York State The next phase of vaccination, 1B, begins this Monday, which includes people aged 75 and
Read MoreNew York is facing the distressing highest peak so far from the second wave of the coronavirus pandemic, and at
Read More[ad_1] Dharamsala, December 3 The first phase of the general election for the Tibetan parliament-in-exile was held on Sunday to
Read More